Wave Life Sciences Ltd. - Ordinary Shares (WVE) News

Wave Life Sciences Ltd. - Ordinary Shares (WVE)

Today's Latest Price: $7.42 USD

0.05 (-0.67%)

Updated Oct 29 1:45pm

Add WVE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Filter WVE News Items

WVE News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest WVE News From Around the Web

Below are the latest news stories about Wave Life Sciences Ltd that investors may wish to consider to help them evaluate WVE as an investment opportunity.

Wave Life Sciences (WVE) Presents at H.C. Wainwright Annual Global Investment Conference - Slideshow

The following slide deck was published by Wave Life Sciences Ltd. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 18, 2020

WAVE Life Sciences: Q2 Earnings Insights

Shares of WAVE Life Sciences (NASDAQ:WVE) moved higher by 1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per …

Benzinga | August 10, 2020

Wave Life Sciences to Webcast Conference Call of Second Quarter 2020 Financial Results on August 10, 2020

CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to…

GlobeNewswire | July 27, 2020

Will Wave Life Sciences (WVE) Report Negative Q2 Earnings? What You Should Know

Wave Life Sciences (WVE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 27, 2020

Are Options Traders Betting on a Big Move in Wave Life Sciences (WVE) Stock?

Investors need to pay close attention to Wave Life Sciences (WVE) stock based on the movements in the options market lately.

Yahoo | June 24, 2020

Edited Transcript of WVE earnings conference call or presentation 11-May-20 12:30pm GMT

Q1 2020 WAVE Life Sciences Ltd Earnings Call

Yahoo | June 18, 2020

Wave Life Sciences to Present at the Jefferies 2020 Virtual Healthcare Conference

CAMBRIDGE, Mass., May 26, 2020 -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people.

Yahoo | May 26, 2020

Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice President, Therapeutics Discovery

Wave Life Sciences Ltd. (WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that it has appointed Kenneth Rhodes, PhD, as Senior Vice President, Therapeutics Discovery. In this newly created position, Dr. Rhodes will be responsible for defining the strategy and guiding discovery research to design new therapeutic candidates and advance them to the clinic, with an initial focus on neurological diseases.

Yahoo | May 18, 2020

WAVE Life Sciences Pte. Ltd. (WVE) Q1 2020 Earnings Call Transcript

On the call with me here today are Dr. Paul Bolno, our President and CEO; David Gaiero, Interim CFO; Dr. Mike Panzara, our Chief Medical Officer; and Dr. Chandra Vargeese, Senior Vice President, Drug Discovery. During the first quarter, I am proud that our team's commitment along with the close partnership and support of our clinical trial site has allowed both PRECISION-HD clinical trials to continue despite the challenges presented by the COVID-19 global pandemic.

Yahoo | May 11, 2020

Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates

Wave Life Sciences (WVE) delivered earnings and revenue surprises of -2.99% and -42.72%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 11, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7444 seconds.